These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12468145)

  • 1. Chemotherapy for advanced non-small cell lung cancer (NSCLC).
    Manegold C
    Lung Cancer; 2002 Dec; 38 Suppl 3():S47-50. PubMed ID: 12468145
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of chemotherapy (CT) and supportive care (SC) in advanced non-small cell lung cancer (NSCLC).
    Thatcher N
    Lung Cancer; 2002 Dec; 38 Suppl 3():S71-3. PubMed ID: 12468151
    [No Abstract]   [Full Text] [Related]  

  • 3. [Maintenance chemotherapy in advanced NSCLC].
    Krazkowski M
    Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S16-8. PubMed ID: 16719150
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy and quality of life in advanced NSCLC.
    Farrugia D; Lewis R
    Br J Cancer; 2001 Jul; 85(1):137-8. PubMed ID: 11437416
    [No Abstract]   [Full Text] [Related]  

  • 5. Gemcitabine--a new agent in the treatment of non-small cell lung cancer. A commentary.
    Carmichael J
    Lung Cancer; 1999 Aug; 25(2):73-5. PubMed ID: 10470840
    [No Abstract]   [Full Text] [Related]  

  • 6. Symptomatic benefit from gemcitabine and other chemotherapy in advanced non-small cell lung cancer: changes in performance status and tumour-related symptoms.
    Thatcher N; Anderson H; Betticher DC; Ranson M
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():39-48. PubMed ID: 8718424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancer.
    Lund B; Ryberg M; Petersen PM; Anderson H; Thatcher N; Dombernowsky P
    Ann Oncol; 1994 Nov; 5(9):852-3. PubMed ID: 7848889
    [No Abstract]   [Full Text] [Related]  

  • 9. Gemcitabine shows promise as combination agent in NSCLC.
    Oncology (Williston Park); 1996 Sep; 10(9):1311. PubMed ID: 9052981
    [No Abstract]   [Full Text] [Related]  

  • 10. Gemcitabine for lung cancer.
    Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
    Niho S; Kubota K; Goto K; Ohmatsu H; Matsumoto T; Kakinuma R; Nishiwaki Y
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):19-24. PubMed ID: 12712259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer.
    Cucević B; Samarzija M; Baricević D; Jakopović M; Redzepi G; Samija M
    Coll Antropol; 2005 Dec; 29(2):583-8. PubMed ID: 16417165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RRM1 expression and clinical outcome of gemcitabine-containing chemotherapy for advanced non-small-cell lung cancer: a meta-analysis.
    Gong W; Zhang X; Wu J; Chen L; Li L; Sun J; Lv Y; Wei X; Du Y; Jin H; Dong J
    Lung Cancer; 2012 Mar; 75(3):374-80. PubMed ID: 21889227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current chemotherapy of advanced non-small cell lung cancer.
    Abratt RP
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():15-8. PubMed ID: 8718420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel and gemcitabine combination in a biweekly schedule in patients with advanced non small-cell lung cancer: a phase I study.
    Athanasiadis A; Roussos G; Papakostoulis T; Athanasiadou DC; Stathopoulos GP
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):653-8. PubMed ID: 15937714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine in non-small cell lung cancer.
    Sørensen JB
    Lung Cancer; 1995 Apr; 12 Suppl 1():S173-5. PubMed ID: 7551926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboplatin and gemcitabine in stage IV non small cell lung cancer: beyond cisplatin in palliative chemotherapy.
    Tassinari D; Fochessati F; Arcangeli V; Panzini I; Ravaioli A; Sartori S
    Lung Cancer; 2003 Jan; 39(1):107-8. PubMed ID: 12499103
    [No Abstract]   [Full Text] [Related]  

  • 18. Results of a phase II trial of gemcitabine in patients with non-small-cell lung cancer and a performance status of 2.
    Neubauer MA; Reynolds CH; Joppert MG; Whitaker T; Ghaddar H; Marsland TA; Asmar L
    Clin Lung Cancer; 2005 Jan; 6(4):245-9. PubMed ID: 15694017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis--a case report.
    Chen YM; Chen MC; Tsai CM; Perng RP
    Lung Cancer; 2003 Apr; 40(1):99-101. PubMed ID: 12660014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine as single agent in the treatment of elderly patients with advanced non small cell lung cancer.
    Altavilla G; Adamo V; Buemi B; Marabello G; Maisano R; Lupo G; Bene A; Bellocco G
    Anticancer Res; 2000; 20(5C):3675-8. PubMed ID: 11268438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.